Crucially, rather than being a static vulnerability factor or trait marker, BDNF is considered as a dynamic “state marker” of depression, reflecting current disease activity and treatment responsiveness, as consistently supported by evidence showing that interventions which effectively reduce depressive symptoms often lead to increased BDNF levels [60,61]. Here, BDNF is linked to depressive symptom measurement.